2020
DOI: 10.14309/01.ajg.0000706000.50740.f3
|View full text |Cite
|
Sign up to set email alerts
|

S0988 Health Outcomes in Patients With Hepatic Encephalopathy Managed Through Telemedicine and a Specialized Pharmacy Team

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In this study, 93 of 457 (20.4%) recommendations from pharmacists were related to medication access (e.g., prior authorization, obtaining nonpreferred therapies, facilitating lower copayments) [ 71 ]. Data from an observational registry study indicated that incorporation of telemedicine and pharmacists in outpatient management of patients with cirrhosis and HE receiving rifaximin improved adherence and outcomes after 6 months compared with published data from a pivotal, phase 3 study of rifaximin [ 43 ]: rifaximin nonadherence (6.4% vs. 15.8%, respectively; P = 0.0006); HE-related hospitalizations (2.7% vs. 13.6%; P < 0.0001); and worsening of HE or mortality (15.6% vs. 26.4%; P < 0.0001) [ 72 ]. Further, in a survey study, patients participating in a pharmacist-led transition of care initiative (i.e., discharge education, medication reconciliation, and follow-up telephone call; n = 414) indicated greater satisfaction compared with patients in a control group ( n = 1314; discharge education only [ n = 368], follow-up telephone call only [ n = 184], or no education or telephone call [ n = 762]) [ 73 ].…”
Section: Reducing Risk Of He-related Hospitalizations In Patients Wit...mentioning
confidence: 99%
“…In this study, 93 of 457 (20.4%) recommendations from pharmacists were related to medication access (e.g., prior authorization, obtaining nonpreferred therapies, facilitating lower copayments) [ 71 ]. Data from an observational registry study indicated that incorporation of telemedicine and pharmacists in outpatient management of patients with cirrhosis and HE receiving rifaximin improved adherence and outcomes after 6 months compared with published data from a pivotal, phase 3 study of rifaximin [ 43 ]: rifaximin nonadherence (6.4% vs. 15.8%, respectively; P = 0.0006); HE-related hospitalizations (2.7% vs. 13.6%; P < 0.0001); and worsening of HE or mortality (15.6% vs. 26.4%; P < 0.0001) [ 72 ]. Further, in a survey study, patients participating in a pharmacist-led transition of care initiative (i.e., discharge education, medication reconciliation, and follow-up telephone call; n = 414) indicated greater satisfaction compared with patients in a control group ( n = 1314; discharge education only [ n = 368], follow-up telephone call only [ n = 184], or no education or telephone call [ n = 762]) [ 73 ].…”
Section: Reducing Risk Of He-related Hospitalizations In Patients Wit...mentioning
confidence: 99%